Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
LHX4
REST API REST API
Homo sapiens
LHX4 is differentially expressed in 120 experiments: 52 organism parts: kidney, oral mucosa, ... (50 more);, 45 disease states: normal, breast carcinoma, ... (43 more);, 46 cell types 128 cell lines 12 compound treatments and 47 other conditions.
Synonyms Gsh4
Orthologs LHX4 (Danio rerio)   F6QIP6_CIOIN (Ciona intestinalis)   LHX4 (Gallus gallus)   Lhx4 (Mus musculus)   Q1MW18_BOVIN (Bos taurus)   Lhx4 (Rattus norvegicus)   Lim3 (Drosophila melanogaster)   LOC100497384 (Xenopus laevis)   LHX4 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term regulation of transcription, DNA-dependent, intracellular, metal ion binding, anti-apoptosis, motor axon guidance, sequence-specific DNA binding, nucleus, organ morphogenesis, zinc ion binding, medial motor column neuron differentiation, sequence-specific DNA binding transcription factor activity
InterPro Term Znf_LIM, Homeobox
UniProt Accession Q96JP7, Q5RLJ3, Q5RLJ2, Q5RLJ1, Q969G2
Gene-Disease Assocation PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4
Search EB-eye ENSG00000121454
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-AFMX-5, E-GEOD-18105, E-MTAB-69, E-GEOD-6919, ... (10 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-22152, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, E-MEXP-2197, ... (14 experiments)

Factor Value U/D Experiments
MCF-7
2
E-GEOD-20081, E-GEOD-5823
SW900
1
E-MTAB-37
WI38
1
E-MTAB-37
THP1
1
E-MTAB-37
DMS153
1
E-MTAB-37
MKN45
1
E-GEOD-15460
122 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-21668, E-GEOD-20677, E-GEOD-4219, E-GEOD-13987, ... (25 experiments)

Factor Value U/D Experiments
induced pluripotent stem cell
2
E-GEOD-18265, E-GEOD-18147
vascular smooth muscle cell
1
E-TABM-130
astrocyte
1
E-GEOD-4483
chondrocyte
1
E-TABM-130
mesendoderm/endoderm progenitor cell
1
E-MEXP-930
human embryonic stem cell
1
E-GEOD-20033
40 more value(s).


Disease state

studied in E-GEOD-3307, E-MEXP-2069, E-GEOD-16363, E-GEOD-9692, E-GEOD-1145, ... (27 experiments)

Factor Value U/D Experiments
control
2
E-GEOD-16363, E-GEOD-21912
renal carcinoma
1
E-MTAB-37
engineered non-invasive esophageal squamous cell carcinoma
1
E-GEOD-21293
gastric carcinoma
1
E-GEOD-15460
oligodendroglioma with EGFR amplification
1
E-MEXP-1507
cervical carcinoma
1
E-GEOD-5823
39 more value(s).


Compound treatment

studied in E-GEOD-3284, E-GEOD-15205, E-TABM-127, E-GEOD-7307, E-GEOD-20081 ... (5 experiments)

Factor Value U/D Experiments
TNF
1
1
E-GEOD-15205
unknown
1
E-GEOD-7307
Cxcl12
1
1
E-GEOD-7307
bacterial endotoxin
1
1
E-GEOD-3284
cigarette smoke
2
1
E-TABM-127
TGF
1
1
E-GEOD-15205
6 more value(s).


Age at diagnosis

studied in E-GEOD-3494

Factor Value U/D Experiments
76
1
1
E-GEOD-3494


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-21589, E-GEOD-16363, E-GEOD-19293 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-MEXP-2359, E-GEOD-4667

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MTAB-108

Genotype
studied in E-MEXP-421, E-TABM-601, E-GEOD-17347

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-MEXP-2657, E-TABM-127, E-GEOD-20540, E-GEOD-10315, E-MEXP-1103, ... (6 experiments)

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-GEOD-19330, E-TABM-666, ... (15 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561, E-GEOD-17400

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-17636

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-1857

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

Sample type
studied in E-TABM-783

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Sirna
studied in E-GEOD-21575

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Processing time: 0.302 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM